WisdomTree BioRevolution Fund Rating $15.37 +0.23 (+1.52%) (As of 11/22/2024 ET) Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatings WisdomTree BioRevolution Fund Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.WDNA Aggregate RatingModerate Buy 2.71Holdings in WDNA have an aggregate rating of Moderate Buy based on 690 analyst ratings issued in the past year covering 47 companies (68.8% of the portfolio).WDNA Aggregate Price Target$15.37High Prediction$15.37Average Prediction$15.37Low Prediction$15.37Holdings in WDNA have an aggregate price target of $15.37 and a range of $15.37 to $15.37 covering 47 companies (68.8% of the portfolio).WDNA Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy8 Buy rating(s)Moderate Buy31 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by WisdomTree BioRevolution Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 47 WDNA Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.19%TWSTTwist Bioscience$42.23+1.4%3.8008 of 5 stars2.67$51.78 22.6%9Analyst ForecastAnalyst RevisionNews Coverage2.90%NTRANatera$167.26-1.2%2.8291 of 5 stars3.00$140.59 -15.9%17Insider TradeNews Coverage2.74%AGIOAgios Pharmaceuticals$55.68+0.3%3.1783 of 5 stars2.50$52.33 -6.0%82.51%BPMCBlueprint Medicines$94.15-2.6%2.7382 of 5 stars2.71$122.11 29.7%21Analyst Revision2.40%IOVAIovance Biotherapeutics$8.55+3.8%4.1094 of 5 stars2.89$22.33 161.2%92.38%GERNGeron$4.07+1.2%3.568 of 5 stars3.00$7.05 73.2%112.18%VCELVericel$59.11+4.2%1.1196 of 5 stars3.00$58.14 -1.6%7Analyst ForecastPositive News2.10%LLYEli Lilly and Company$748.01-0.3%4.9845 of 5 stars2.81$1,007.94 34.8%21Analyst RevisionPositive News2.03%VCYTVeracyte$39.59+1.7%4.1739 of 5 stars2.78$41.25 4.2%91.82%UTHRUnited Therapeutics$372.89+1.5%4.5426 of 5 stars2.73$370.86 -0.5%15Insider TradeAnalyst RevisionPositive News1.64%BBIOBridgeBio Pharma$23.42+0.8%4.5978 of 5 stars2.87$47.57 103.1%15Insider TradeNews Coverage1.59%VRTXVertex Pharmaceuticals$450.97+0.1%4.0789 of 5 stars2.55$504.38 11.8%29Analyst DowngradeAnalyst RevisionPositive News1.52%ALNYAlnylam Pharmaceuticals$244.89-0.8%4.5214 of 5 stars2.71$298.09 21.7%24Analyst ForecastAnalyst Revision1.44%RAREUltragenyx Pharmaceutical$47.24+2.7%4.6691 of 5 stars2.92$87.46 85.1%13Analyst Forecast1.41%SRPTSarepta Therapeutics$114.23+3.4%4.9352 of 5 stars3.00$181.33 58.7%22Analyst DowngradePositive News1.41%CTLTCatalent$60.98+2.2%3.0742 of 5 stars2.00$63.40 4.0%7Analyst DowngradeHigh Trading Volume1.40%AMGNAmgen$294.53+1.6%4.9228 of 5 stars2.46$333.57 13.3%26Analyst RevisionPositive News1.39%DDDuPont de Nemours$83.32+0.7%4.4281 of 5 stars2.54$95.42 14.5%13Positive News1.35%FOLDAmicus Therapeutics$9.66+1.7%4.5811 of 5 stars2.89$17.63 82.5%91.34%GILDGilead Sciences$90.19+0.5%4.5148 of 5 stars2.65$95.41 5.8%26Analyst ForecastAnalyst RevisionNews CoveragePositive News1.33%DHRDanaher$235.84+0.3%4.95 of 5 stars2.74$287.16 21.8%19Analyst RevisionNews CoveragePositive News1.24%STOKStoke Therapeutics$11.43+1.4%3.8638 of 5 stars3.00$20.83 82.3%91.22%NEONeoGenomics$16.39+6.5%2.5706 of 5 stars3.00$20.25 23.6%91.21%CRSPCRISPR Therapeutics$47.88+3.4%1.4336 of 5 stars2.37$74.94 56.5%191.20%LHLaboratory Co. of America$239.67-0.2%4.7946 of 5 stars2.80$255.92 6.8%15Positive News1.15%DARDarling Ingredients$40.13-2.5%4.2365 of 5 stars2.78$53.44 33.2%91.15%REGNRegeneron Pharmaceuticals$738.00-0.9%4.8161 of 5 stars2.78$1,099.55 49.0%23Positive News1.15%BMYBristol-Myers Squibb$58.87+1.1%4.8167 of 5 stars2.20$54.07 -8.2%20Analyst RevisionPositive News1.14%FATEFate Therapeutics$2.29+10.6%3.9475 of 5 stars2.30$6.75 194.8%10Analyst Forecast1.14%TMOThermo Fisher Scientific$513.26-0.6%4.9919 of 5 stars2.86$649.33 26.5%22Buyback AnnouncementPositive News1.14%TSNTyson Foods$63.774.363 of 5 stars1.89$60.67 -4.9%9Insider Trade1.14%ZTSZoetis$176.96+0.1%4.8765 of 5 stars3.10$221.44 25.1%10Positive News1.13%CTVACorteva$61.23+0.8%4.3742 of 5 stars2.65$64.33 5.1%20Analyst ForecastBuyback AnnouncementNews Coverage1.12%BEAMBeam Therapeutics$25.05+6.2%2.9853 of 5 stars2.75$44.91 79.3%121.12%IONSIonis Pharmaceuticals$34.01+0.2%4.1115 of 5 stars2.68$60.65 78.3%191.12%QGENQiagen$42.78+1.1%4.2271 of 5 stars2.60$50.88 18.9%101.11%JNJJohnson & Johnson$155.17-0.2%4.9595 of 5 stars2.53$175.94 13.4%15News CoveragePositive News1.11%ILMNIllumina$140.14+2.3%4.5418 of 5 stars2.67$164.00 17.0%241.10%MYGNMyriad Genetics$15.49+2.4%4.2934 of 5 stars2.42$27.36 76.7%12Analyst Downgrade1.04%BNTXBioNTech$113.13+4.5%2.8074 of 5 stars2.81$138.79 22.7%16Analyst Forecast1.03%TECHBio-Techne$71.28+0.3%4.8042 of 5 stars2.67$81.78 14.7%9News Coverage1.03%DOWDOW$45.46+1.5%4.811 of 5 stars2.31$57.27 26.0%13News CoveragePositive News1.01%ARCTArcturus Therapeutics$16.91-0.9%2.5015 of 5 stars3.13$71.40 322.2%81.01%RGENRepligen$142.58+0.6%4.6676 of 5 stars2.73$190.25 33.4%11Analyst UpgradeNews Coverage1.01%MRKMerck & Co., Inc.$99.18-0.7%4.9978 of 5 stars2.68$130.86 31.9%19Dividend IncreaseAnalyst RevisionNews CoveragePositive News0.98%AZNAstraZeneca$65.63+2.1%3.8886 of 5 stars2.92$89.75 36.8%12Analyst UpgradeAnalyst RevisionGap Up0.97%BIOBio-Rad Laboratories$332.91+2.3%4.7382 of 5 stars2.60$391.80 17.7%5Analyst Revision This page (BATS:WDNA) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WisdomTree BioRevolution Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share WisdomTree BioRevolution Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free WDNA Stock Alerts